Is there still a role for Abiraterone left to fulfil in clinical use? Based on what criteria should the choice between APA and Enzalutamide be made? Questions such as these and more will be answered in this interview with Prof. Chi (CA).
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.I agreeRead More
